| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 01/19/2012 | WO2012006962A1 Truncated human papillomavirus type 58 l1 protein |
| 01/19/2012 | WO2012006958A1 Amids substituted indazole derivativees as ploy(adp-ribose)polymerase inhibitors |
| 01/19/2012 | WO2012006946A1 Anti-wssv and/or tsv nucleic acid drug |
| 01/19/2012 | WO2012006864A1 Triterpenoid saponin compounds, preparation methods and uses thereof |
| 01/19/2012 | WO2012006727A1 Human papillomavirus e7 antigen compositions and uses thereof |
| 01/19/2012 | WO2012006680A1 7, 9-nitrogen radical-4-oxo-4h-pyrido[l,2-a]pyrimidine-2-carboxylic acid benzylamide anti-virals |
| 01/19/2012 | WO2012006667A1 Method of treatment of hiv or aids |
| 01/19/2012 | WO2011137319A3 Stabilized fibronectin domain compositions, methods and uses |
| 01/19/2012 | WO2011117870A3 Compositions for topical administration |
| 01/19/2012 | WO2011116262A3 Compositions and methods for diagnosing and treating urinary tract infections |
| 01/19/2012 | WO2011112983A3 Psrp is a protective antigen against pneumococcal infection |
| 01/19/2012 | WO2011112850A3 Humanized and chimeric anti-properdin antibodies |
| 01/19/2012 | WO2011109285A3 Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients |
| 01/19/2012 | WO2011098762A3 Antibodies against cxcr4 |
| 01/19/2012 | US20120016467 Polymer-based, sustained release drug delivery system |
| 01/19/2012 | US20120016289 Articles, compositions, and methods for killing or preventing the growth of microbes |
| 01/19/2012 | US20120016038 Compositions and methods for altering the rate of hydrolysis of cured oil-based materials |
| 01/19/2012 | US20120016034 Polymorphic Form Of N-(S)-(3,4-Difluoro-2-(2-Fluoro-4-Iodophenylamino)-6-Methoxyphenyl)-1-(2,3-Dihydroxypropyl)Cyclopropane-1-Sulfonamide And Uses Thereof |
| 01/19/2012 | US20120016005 Phagocytic cell delivery of rnai |
| 01/19/2012 | US20120015998 Phototherapy methods and devices comprising emissive aryl-heteroaryl compounds |
| 01/19/2012 | US20120015997 Pharmaceutical composition for external use |
| 01/19/2012 | US20120015996 Antifungal medicinal compositions |
| 01/19/2012 | US20120015988 Sulfone Compounds Which Modulate The CB2 Receptor |
| 01/19/2012 | US20120015986 Salts of dehydroacetic acid as a pyrithione stabilizer in plastics |
| 01/19/2012 | US20120015983 Synthesis and Novel Salt Forms of (R)-3-((E)-pyrrolidin-3-yl)vinyl)-5-tetrahydropyran-4-yloxy)pyridine |
| 01/19/2012 | US20120015979 Compounds for Modulating TRPV3 Function |
| 01/19/2012 | US20120015971 Ophthalmic composition comprising ascomycin |
| 01/19/2012 | US20120015967 Pyrimidine and pyridine derivatives as posh and posh-ap inhibitors |
| 01/19/2012 | US20120015966 Ppar active compounds |
| 01/19/2012 | US20120015952 Inhibitors of NF-KB |
| 01/19/2012 | US20120015950 Carbamate derivatives of alkyl-heterocycles, preparation thereof and therapeutic use thereof |
| 01/19/2012 | US20120015941 Antibacterial Amide and Sulfonamide Substituted Heterocyclic Urea Compounds |
| 01/19/2012 | US20120015931 Purine compounds selective for pi3k p110 delta, and methods of use |
| 01/19/2012 | US20120015926 Compounds for the treatment of inflammatory disorders |
| 01/19/2012 | US20120015920 Heterobicyclic metalloprotease inhibitors |
| 01/19/2012 | US20120015912 Use of 2,5-dihydroxybenzene for the treatment of ocular diseases |
| 01/19/2012 | US20120015907 Furopyridine compounds and uses thereof |
| 01/19/2012 | US20120015902 Arabinoxylo-oligosaccharides useful against gastrointestinal infections |
| 01/19/2012 | US20120015897 Novel formulation for treating fungal infections |
| 01/19/2012 | US20120015896 Anti-Penicillin Resistant Pneumococci Agent and Novel 16-Membered Macrolide Derivative |
| 01/19/2012 | US20120015895 Use Of RR/SR-Ractopamine |
| 01/19/2012 | US20120015874 Novel inhibitors of retroviral reverse transcriptace |
| 01/19/2012 | US20120015873 Melanocortin analogs with antimicrobial activity |
| 01/19/2012 | US20120015872 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120015871 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120015870 Peptides and compositions for prevention of cell adhesion and methods of using same |
| 01/19/2012 | US20120015867 Therapeutic peptides and method |
| 01/19/2012 | US20120015402 Method of Proliferating Plasma Cells |
| 01/19/2012 | US20120015331 Scaffold |
| 01/19/2012 | US20120015051 Chlorite Formulations and Methods of Preparation and Use Thereof |
| 01/19/2012 | US20120015045 Functionalized fullerenes as antifungal agents |
| 01/19/2012 | US20120015040 Dendritic Cell Precursor Populations, Dendritic Cell Populations Derived Therefrom and Uses Thereof |
| 01/19/2012 | US20120014995 Pharmaceutical compositions and methods to vaccinate against disseminated candidiasis and other infectious agents |
| 01/19/2012 | US20120014991 Novel, non-antigenic, mucosal adjuvant formulation which modulates the effects of substances, including vaccine antigens, in contact with mucosal body surfaces |
| 01/19/2012 | US20120014989 PYRROLO[2,3-b]PYRIDIN-4-YL-AMINES AND PYRROLO[2,3-b]PYRIMIDIN-5-YL-AMINES AS JANUS KINASE INHIBITORS |
| 01/19/2012 | US20120014983 recombinant alpha-hemolysin polypeptide of staphylococcus aureus, having a deletion in the stem domain and heterologous sequences inserted |
| 01/19/2012 | US20120014982 Methods and Compositions for Immunizing Against Chlamydia Infection |
| 01/19/2012 | US20120014981 Avirulent, immunogenic flavivirus chimeras |
| 01/19/2012 | US20120014972 Influenza virus compositions and methods for universal vaccines |
| 01/19/2012 | US20120014963 Probiotics, secretory iga and infection |
| 01/19/2012 | US20120014952 Complement receptor 2 targeted complement modulators |
| 01/19/2012 | US20120014947 Methods and compositions to reduce liver damage associated with conditions or therapies that affect the immune system |
| 01/19/2012 | US20120014945 Anti-Dengue Virus Antibodies |
| 01/19/2012 | US20120014943 Optimized Anti-CD30 Antibodies |
| 01/19/2012 | US20120014928 Methods and compositions for targeted cleavage and recombination |
| 01/19/2012 | US20120014920 Annexin and its use to treat inflammatory disorders |
| 01/19/2012 | US20120014917 Methods of treating hiv patients with anti-fibrotics |
| 01/19/2012 | US20120014916 Polyalkylene polymer compounds and uses thereof |
| 01/19/2012 | US20120014914 Inhibitors of serine proteases, particularly hcv ns3-ns4a proteases |
| 01/19/2012 | US20120014913 Process for preparing antiviral compounds |
| 01/19/2012 | US20120014912 Palatable pharmaceutical composition |
| 01/19/2012 | US20120014911 Regulators of the Interferon-Alpha Receptor 1 (IFNAR1) Chain of the Interferon Receptor |
| 01/19/2012 | US20120014893 Antimycotic pharmaceutical composition |
| 01/19/2012 | US20120014884 Menthol-derivative compounds and use thereof as oral and systemic active agents |
| 01/19/2012 | US20120014883 Compositions Comprising Derivatives Of Essential Oil Compounds And Use In Personal Care Products |
| 01/19/2012 | CA2805748A1 Process for preparing antiviral compounds |
| 01/19/2012 | CA2805300A1 Human papillomavirus e7 antigen compositions and uses thereof |
| 01/19/2012 | CA2804697A1 Formulation comprising a type b lantibiotic |
| 01/18/2012 | EP2407545A1 Auxotrophic, recombinant bcg strain pasteur and use thereof for combating human infections caused by parasites |
| 01/18/2012 | EP2407537A1 Humanized pcrv antibody having anti-pseudomonal activity |
| 01/18/2012 | EP2407473A2 Method for producing phosphorus-containing compounds |
| 01/18/2012 | EP2406206A1 Tetrahydronaphthalen-2-ol derivatives |
| 01/18/2012 | EP2405909A1 Compositions and methods for elimination of gram-negative bacteria |
| 01/18/2012 | EP2321306B1 3-cyanopyrrolidinyl-phenyl-oxazolidinones as antibacterial agents |
| 01/18/2012 | EP2310395B1 9-substituted-b-carboxy-oxadiazino-quinolone derivatives, their preparation and their application as anti-bacterials |
| 01/18/2012 | EP2271665B1 Highly bridged peptides from actinomadura namibiensis |
| 01/18/2012 | EP2220076B1 Inhibitors of human immunodeficiency virus replication |
| 01/18/2012 | EP2195317B1 2,3-substituted azaindole derivatives for treating viral infections |
| 01/18/2012 | EP1877411B1 Diaryl-purine, azapurines and -deazapurines as non-nucleoside reverse transcriptase inhibitors for treatment of hiv |
| 01/18/2012 | EP1486213B1 The use of the total coumarins of cnidium monnieri in preparation of the medicament for treating psoriasis |
| 01/18/2012 | EP1292709B1 Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds |
| 01/18/2012 | EP1013661B1 2'-O,4'-C-methylene bicyclonucleosides |
| 01/18/2012 | CN1903860B Technology of preparing high purity cefotamei sodium by solvent process and its medical use |
| 01/18/2012 | CN102325796A Anti-human [alpha]9 integrin antibody and use thereof |
| 01/18/2012 | CN102325783A Synthesis of purine nucleosides |
| 01/18/2012 | CN102325769A Monocarbams |
| 01/18/2012 | CN102325532A Inhalation of levofloxacin for reducing lung inflammation |
| 01/18/2012 | CN102321653A Applications of man-mouse chimeric CD4 (cluster of differentiation 4) plasmid and multiclonal antibody in inhibiting HIV (human immunodeficiency virus) infection |
| 01/18/2012 | CN102321652A Dual expression vector of immunostimulatory RNA and liver cancer target gene Pim-3 silent RNA and application thereof |
| 01/18/2012 | CN102321639A Preparation method of virus-like particles (VLPs) of Chikungunya virus (CHIKV) and its application |